Source:http://linkedlifedata.com/resource/umls/id/C1879508
NCI: A regimen consisting of cytarabine (Ara-C), idarubicin and etoposide, used as an induction treatment for pediatric acute myeloid leukemia (AML).
Download in:
View as
